Publications by authors named "Seth M Arum"

Article Synopsis
  • The study evaluated vutrisiran, an RNA therapy aimed at reducing transthyretin (TTR) production, in patients with hereditary transthyretin (ATTRv) amyloidosis affecting the nerves.
  • The phase 3 HELIOS-A trial involved 164 patients, comparing vutrisiran (administered every 3 months) to patisiran (administered every 3 weeks) and an external placebo group, assessing various health outcomes over 18 months.
  • Results showed that vutrisiran led to significant improvements in neuropathy scores and quality of life compared to placebo, with a good safety profile and no serious drug-related complications.*
View Article and Find Full Text PDF

The Kidney Disease: Improving Global Outcomes (KDIGO) work group released recommendations in 2006 to define the bone-related pathology associated with chronic kidney disease as renal osteodystrophy. In 2009, KDIGO released revised clinical practice guidelines which redefined systemic disorders of bone and mineral metabolism due to chronic kidney disease as chronic kidney disease-mineral and bone disorders. Conditions under this overarching term include osteitis fibrosa cystica, osteomalacia, and adynamic bone disease.

View Article and Find Full Text PDF

Vitamin D deficiency is increasingly being recognized as a prevalent problem in the general population. Patients with chronic lung diseases such as asthma, cystic fibrosis, chronic obstructive lung disease and interstitial pneumonia appear to be at increased risk for vitamin D deficiency for reasons that are not clear. Several studies indicate that vitamin D possesses a range of anti-inflammatory properties and may be involved in processes other than the previously believed functions of calcium and phosphate homeostasis.

View Article and Find Full Text PDF
New developments surrounding the safety of bisphosphonates.

Curr Opin Endocrinol Diabetes Obes

December 2008

Purpose Of Review: Several new issues have been linked with the use of bisphosphonates in recent years. This has complicated the use of this important class of agents. This article reviews data surrounding these issues and discusses the impact on patient care.

View Article and Find Full Text PDF

We present the case of a 38-yr-old man with a sporadic, multifocal pheochromocytoma and paraganglioma who was discovered to carry a Y791F germline mutation in exon 13 of the RET proto-oncogene. This mutation was found in his 65-yr-old mother and his 86-yr-old maternal grandmother. Neither of them had either biochemical evidence of pheochromocytoma or medullary thyroid carcinoma.

View Article and Find Full Text PDF

Pheochromocytomas are neural crest-derived tumors that arise from inherited or sporadic mutations in at least six independent genes. The proteins encoded by these multiple genes regulate distinct functions. We show here a functional link between tumors with VHL mutations and those with disruption of the genes encoding for succinate dehydrogenase (SDH) subunits B (SDHB) and D (SDHD).

View Article and Find Full Text PDF